Credit Suisse’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-130,424
| Closed | -$1.46M | – | 3773 |
|
|
2017
Q3 | $1.46M | Sell |
130,424
-149,917
| -53% | -$1.68M | ﹤0.01% | 2382 |
|
|
2017
Q2 | $3.09M | Buy |
280,341
+98,595
| +54% | +$1.08M | ﹤0.01% | 1636 |
|
|
2017
Q1 | $1.78M | Sell |
181,746
-15,172
| -8% | -$149K | ﹤0.01% | 2112 |
|
|
2016
Q4 | $2.13M | Buy |
196,918
+139,586
| +243% | +$1.51M | ﹤0.01% | 2104 |
|
|
2016
Q3 | $588K | Sell |
57,332
-59,823
| -51% | -$614K | ﹤0.01% | 3013 |
|
|
2016
Q2 | $1.53M | Sell |
117,155
-186,522
| -61% | -$2.44M | ﹤0.01% | 2297 |
|
|
2016
Q1 | $3.34M | Buy |
303,677
+243,236
| +402% | +$2.68M | ﹤0.01% | 1614 |
|
|
2015
Q4 | $556K | Buy |
60,441
+29,901
| +98% | +$275K | ﹤0.01% | 3078 |
|
|
2015
Q3 | $212K | Sell |
30,540
-156,200
| -84% | -$1.08M | ﹤0.01% | 3687 |
|
|
2015
Q2 | $1.83M | Buy |
186,740
+43,849
| +31% | +$431K | ﹤0.01% | 2391 |
|
|
2015
Q1 | $1.27M | Sell |
142,891
-27,012
| -16% | -$240K | ﹤0.01% | 2537 |
|
|
2014
Q4 | $1.49M | Buy |
169,903
+77,546
| +84% | +$680K | ﹤0.01% | 2479 |
|
|
2014
Q3 | $636K | Buy |
92,357
+13,246
| +17% | +$91.2K | ﹤0.01% | 3072 |
|
|
2014
Q2 | $417K | Sell |
79,111
-26,841
| -25% | -$141K | ﹤0.01% | 3514 |
|
|
2014
Q1 | $482K | Sell |
105,952
-4,748
| -4% | -$21.6K | ﹤0.01% | 3376 |
|
|
2013
Q4 | $558K | Sell |
110,700
-34,587
| -24% | -$174K | ﹤0.01% | 3282 |
|
|
2013
Q3 | $737K | Buy |
145,287
+92,415
| +175% | +$469K | ﹤0.01% | 2799 |
|
|
2013
Q2 | $262K | Buy |
+52,872
| New | +$262K | ﹤0.01% | 3316 |
|